See every side of every news story

Published 1 day ago • loading... • Updated 1 day ago

Fosun Pharma's Small Molecule Innovative Drug XH-S004 Achieves Overseas Licensing for a Potential Total of $645 Million

Fosun Pharma announced that its subsidiary has signed a License Agreement with Expedition Therapeutics Inc. to develop XH-S004 globally, excluding certain regions.
Expedition will pay Fosun Pharma up to $120 million for initial payments and a potential total of $525 million based on sales milestones.
XH-S004 is currently in clinical trials in China for non-cystic fibrosis bronchiectasis and chronic obstructive pulmonary disease.
The collaboration aims to enhance global access to XH-S004, benefiting patients with this innovative therapy as early as possible.

Insights by Ground AI

Does this summary seem wrong?

76 Articles

76 Articles

biopharmadive.com

Expedition, a startup searching for drugs from China, cuts its first deal

The startup agreed to pay Fosun Pharma as much as $645 million for a drug in testing for multiple lung conditions, including bronchiectasis.

1 day ago

Read Full Article

PR Newswire

Charleston Gazette-Mail

Johnson City Press

NNY360

WBOC 16

The Daily Advance

TBNweekly

The Daily News

Delaware Business Now

journalgazette.net

The Herald-Dispatch

The State Journal

Brattleboro Reformer

Madison Courier

ashepostandtimes.com

Record Argus - Serving Greenville, PA since 1848

Islander News

Bennington Banner

The Progress

The Northern Virginia Daily

The Berkshire Eagle

Rutland Herald

Tullahoma News

The Coal Valley News

Suncoast News

The Transylvania Times

Times Argus

The Logan Banner

Sun Newspapers

Laotian Times

The Westerly Sun

newportplaintalk.com

Hometown News Treasure Coast

Morgan County Citizen

The Times-News

The Conway Daily Sun

Williamson Herald

stonecountyenterprise.com

Chatham Star Tribune

Smith Mountain Eagle

Finger Lakes Times

The Daily News - Jacksonville, NC

The Clarion News

The Daily Press

Biltmore Beacon

Times Virginian

keenesentinel.com

The Elkin Tribune

Saint Albans Messenger

News of Orange

Yadkin Ripple

blockislandtimes.com

thesentinel.com

Fairfax County Times

Essex Reporter

The Ridgway Record

willistonobserver.com

theohiopressnetwork.com

theritchiegazette.com

daily-tribune.com

Observer News Enterprise

swrankinnews.com

starkvilledailynews.com

The Inquirer and Mirror

Daytona Times

Coastal Point

www.Arundel.News

tallasseetribune.com

The Courier-Tribune

The Free Press

dailytimesleader.com

mountaineagle.com

grundycountyherald.com

+73 Reposted by 73 other sources

Fosun Pharma's Small Molecule Innovative Drug XH-S004 Achieves Overseas Licensing for a Potential Total of $645 Million

SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- On August 11, Fosun Pharma (SSE:600196, HKEX: 02196) announced that its subsidiary Fosun Pharma Industrial has signed a License Agreement with Expedition Therapeutics Inc.(Expedition) to grant Expedition the rights to develop, manufacture, and commercialize…

1 day ago·Buffalo, United States

Read Full Article

pharmaceutical-technology.com

Fosun signs $645m licensing deal with Expedition

Fosun Pharma Industrial has entered a licence agreement to grant ex-China rights for its respiratory drug, XH-S004, to Expedition.

1 day ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources76

Leaning Left7Leaning Right7Center30Last Updated12 hours agoBias Distribution

68% Center

Bias Distribution

68% of the sources are Center

68% Center

+2

+25

Untracked bias

+23

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States 1 day ago on Tuesday, August 12, 2025.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics